Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...

Cardiology training today exists in a paradox. As the specialty becomes more complex, particularly in procedural domains, the ...

Background Renal denervation (RDN) has emerged as a guideline-recommended therapeutic option in hypertension management with ...

3 Department of Cardiothoracic Surgery, National Heart and Lung Institute, Imperial College Correspondence to: Dr I Nadra Department of Cardiology, National Heart and Lung Institute, Imperial College, ...

Correspondence to Prof Hugh Tunstall-Pedoe, Cardiovascular Epidemiology Unit, Institute of Cardiovascular Research, University of Dundee, Ninewells Hospital, Dundee DD1 9SY, UK; ...

Correspondence to Dr Carl J Lavie, Cardiology, John Ochsner Heart and Vascular Institute, New Orleans, LA 70121, USA; clavie{at}ochsner.org In their Heart paper, O'Keeffe and colleagues4 use data from ...

Background Although oxygen therapy has been used for over a century in the management of patients with suspected acute myocardial infarction (AMI), recent studies have raised concerns around the ...

Background Recent cardiovascular risk equations from the USA and United Kingdom use routinely collected electronic medical records (EMRs), while current equations used in Australia (AusCVDRisk) have ...

Isolated tricuspid regurgitation (TR) can be caused by primary valvular abnormalities such as flail leaflet or secondary annular dilation as is seen in atrial fibrillation, pulmonary hypertension and ...

Department of Cardiological Sciences, St George’s Hospital Medical School, London, UK Correspondence to: Dr Yee Guan Yap Department of Cardiological Sciences, St George’s Hospital Medical School, ...

Percutaneous coronary intervention (PCI) continues to advance at pace with an ever-broadening indication. In this article we will review the recent technological advances in PCI that have enabled more ...

Objective ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are widely prescribed in patients with high cardiovascular (CV) risk. However, whether both classes have equivalent ...